Outpatient-based treatment protocols in the management of venous thromboembolic disease

American Journal of Managed Care

Volumn 6, Issue 20 SUPPL., 2000, Pages

  Spyropoulos, A C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; HEPARIN BINDING PROTEIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; WARFARIN;

BLEEDING; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG MONITORING; DRUG PROTEIN BINDING; DRUG SAFETY; HEALTH CARE COST; HUMAN; LUNG EMBOLISM; MANAGED CARE; META ANALYSIS; OUTPATIENT CARE; PATIENT SATISFACTION; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTOPENIA; THROMBOEMBOLISM;

AMBULATORY CARE; ARIZONA; CLINICAL PROTOCOLS; EMERGENCY TREATMENT; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MANAGED CARE PROGRAMS; ORGANIZATIONAL CASE STUDIES; PATIENT SELECTION; PROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOSIS; WARFARIN;

EID: 0033665680     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Heparin-induced thrombocytopenia is more common with unfractionated heparin than with low-molecular weight heparin
2. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
3. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
4. Criteria for outpatient management of proximal lower extremity deep venous thrombosis
5. Outcomes analyses of the outpatient treatment of venous thromboembolic disease using the low-molecular-weight heparin enoxaparin in a managed care organization
6. Abbreviated hospitalization for deep venous thrombosis with the use of ardeparin
7. Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism
8. Outpatient treatment of pulmonary embolism with dalteparin
9. Low-molecular weight heparin in the treatment of patients with venous thromboembolism
10. Safety of low-molecular-weight-heparin in pregnancy: A system review
11. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: A comparison of patient self-injection with homecare injection
12. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular weight heparin
13. Cost-justification of a clinical pharmacist-managed anticoagulation clinic
14. Thrombotic and hemorrhagic complications in patients with mechanical hear valve prosthesis attending an anticoagulation clinic
15. Outcome analysis of pharmacist-managed anticoagulation service
16. Comparison of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes, and health care costs
17. Antithrombotic therapy for venous thromboembolic disease
18. A randomized trial comparing 5-mg and 10-mg warfarin loading doses
19. A structured teaching and self-management program for patients receiving oral anticoagulation: A randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation